Necrotizing Gingivostomatitis Treatment Market Size

  • Report ID: 3570
  • Published Date: Jul 24, 2024
  • Report Format: PDF, PPT

Necrotizing Gingivostomatitis Treatment Market Size

Necrotizing Gingivostomatitis Treatment Market size was valued at USD 15.99 Million in 2023 and is anticipated to cross USD 36.7 Million by the end of 2036, expanding at more than 6.6% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of necrotizing gingivostomatitis treatment is estimated at USD 16.94 Million. The growth of the market can be attributed to the increasing prevalence of gingivostomatitis in children across the world. The growing incidence of bacterial growth in the mouth owing to a lack of oral health habits is estimated to boost the market growth. Not brushing and flossing teeth on daily basis owing to a lack of awareness and education among illiterate people is expected to fuel the market growth in the coming years.  More than 70% of the American population brush their teeth only once a day as per the estimations in 2021.

The habit of oral sex with the infected person is also estimated to increase the risk of occurrence of gingivostomatitis in the people which thereby hike the market growth across the world. The growing use of antibiotics and over-the-counter (OTC) drugs for minor oral sores and injuries is also estimated to drive market growth. The market growth is also attributed to the increasing prevalence of HIV among adults owing to multiple sex partners or sex with an infected person. HIV makes the patient immunosuppressant leading to the incidence of more infections. According to the reports, the number of people in the U.S. living with HIV was estimated to be more than 1 million with over 33,000 new infections per annum during 2021.


Necrotizing Gingivostomatitis Treatment Market
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3570
  • Published Date: Jul 24, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of necrotizing gingivostomatitis treatment is estimated at USD 16.94 Million.

The necrotizing gingivostomatitis treatment market size was valued at USD 15.99 Million in 2023 and is anticipated to cross USD 36.7 Million by the end of 2036, expanding at more than 6.6% CAGR during the forecast period i.e., between 2024-2036. Increasing incidences of necrotizing gingivostomatitis and the rising use of public toilets are the major factors driving the market growth.

North America is poised to be the largest with a share of about 39% by 2036, attributed to high prevalence of lifestyle diseases, caused by inactive routines, busy lifestyles, and unhealthy eating habits.

Novartis International AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sanofi S.A., GlaxoSmithKline plc, Merck & Co., Inc., Otsuka Pharmaceutical Co., Ltd., Abbott Laboratories, Eli Lilly and Company, Hindustan Antibiotics Limited, Aviro Health L.P.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample